Pilot trial of paclitaxel-Herceptin [trastuzumab] adjuvant therapy for early stage breast cancer

Trial Profile

Pilot trial of paclitaxel-Herceptin [trastuzumab] adjuvant therapy for early stage breast cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2015

At a glance

  • Drugs Paclitaxel (Primary) ; Trastuzumab (Primary) ; Cyclophosphamide; Doxorubicin; Tamoxifen
  • Indications Breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Dec 2015 Results published in the British Journal of Cancer
    • 22 Dec 2006 Status change
    • 27 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top